{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:16:49Z","timestamp":1791001009781,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFA0103204"],"award-info":[{"award-number":["2017YFA0103204"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770887"],"award-info":[{"award-number":["81770887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670830"],"award-info":[{"award-number":["81670830"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation of China","award":["81770887"],"award-info":[{"award-number":["81770887"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00417-020-04797-3","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T08:03:51Z","timestamp":1593763431000},"page":"2407-2418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inhibition of retinal neovascularization by VEGF siRNA delivered via bioreducible lipid-like nanoparticles"],"prefix":"10.1007","volume":"258","author":[{"given":"Zonghua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1718-0453","authenticated-orcid":false,"given":"Liqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"issue":"4","key":"4797_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4103\/jovr.jovr_67_18","volume":"13","author":"M Farnoodian","year":"2018","unstructured":"Farnoodian M, Sorenson CM, Sheibani N (2018) Negative regulators of angiogenesis, ocular vascular homeostasis, and pathogenesis and treatment of exudative AMD. J Ophthalmic Vis Res 13(4):470\u2013486. https:\/\/doi.org\/10.4103\/jovr.jovr_67_18","journal-title":"J Ophthalmic Vis Res"},{"key":"4797_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-vision-091517-034018","volume":"4","author":"Y Sun","year":"2018","unstructured":"Sun Y, Smith LEH (2018) Retinal vasculature in development and diseases. Annu Rev Vis Sci 4:101\u2013122. https:\/\/doi.org\/10.1146\/annurev-vision-091517-034018","journal-title":"Annu Rev Vis Sci"},{"key":"4797_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40942-017-0084-9","volume":"3","author":"T Cabral","year":"2017","unstructured":"Cabral T, Mello LGM, Lima LH, Polido J, Regatieri CV, Belfort R Jr, Mahajan VB (2017) Retinal and choroidal angiogenesis: a review of new targets. Int J Retina Vitreous 3:31. https:\/\/doi.org\/10.1186\/s40942-017-0084-9","journal-title":"Int J Retina Vitreous"},{"issue":"1","key":"4797_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/aos.12049","volume":"92","author":"G Cavallaro","year":"2014","unstructured":"Cavallaro G, Filippi L, Bagnoli P, La Marca G, Cristofori G, Raffaeli G, Padrini L, Araimo G, Fumagalli M, Groppo M, Dal Monte M, Osnaghi S, Fiorini P, Mosca F (2014) The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol 92(1):2\u201320. https:\/\/doi.org\/10.1111\/aos.12049","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"4797_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","volume":"122","author":"ME Hartnett","year":"2015","unstructured":"Hartnett ME (2015) Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 122(1):200\u2013210. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.050","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"4797_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C (2013) Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 74(Suppl 1):35\u201349. https:\/\/doi.org\/10.1038\/pr.2013.205","journal-title":"Pediatr Res"},{"issue":"12","key":"4797_CR7","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1167\/iovs.08-2584","volume":"49","author":"LE Smith","year":"2008","unstructured":"Smith LE (2008) Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture. Invest Ophthalmol Vis Sci 49(12):5177\u20135182. https:\/\/doi.org\/10.1167\/iovs.08-2584","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"4797_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/bjo.2008.145391","volume":"93","author":"JM Ruiz-Moreno","year":"2009","unstructured":"Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S (2009) Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome. Br J Ophthalmol 93(4):448\u2013451. https:\/\/doi.org\/10.1136\/bjo.2008.145391","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4797_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1053\/j.semperi.2015.12.006","volume":"40","author":"KD Beharry","year":"2016","unstructured":"Beharry KD, Valencia GB, Lazzaro DR, Aranda JV (2016) Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity. Semin Perinatol 40(3):189\u2013202. https:\/\/doi.org\/10.1053\/j.semperi.2015.12.006","journal-title":"Semin Perinatol"},{"issue":"3","key":"4797_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","volume":"172","author":"A Stahl","year":"2018","unstructured":"Stahl A, Krohne TU, Eter N, Oberacher-Velten I, Guthoff R, Meltendorf S, Ehrt O, Aisenbrey S, Roider J, Gerding H, Jandeck C, Smith LEH, Walz JM (2018) Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial. JAMA Pediatr 172(3):278\u2013286. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.4838","journal-title":"JAMA Pediatr"},{"issue":"1","key":"4797_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jaapos.2009.12.002","volume":"14","author":"HA Mintz-Hittner","year":"2010","unstructured":"Mintz-Hittner HA (2010) Avastin as monotherapy for retinopathy of prematurity. Journal of AAPOS 14(1):2\u20133. https:\/\/doi.org\/10.1016\/j.jaapos.2009.12.002","journal-title":"Journal of AAPOS"},{"issue":"8","key":"4797_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1001\/archophthalmol.2008.1","volume":"126","author":"L Kong","year":"2008","unstructured":"Kong L, Mintz-Hittner HA, Penland RL, Kretzer FL, Chevez-Barrios P (2008) Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study. Arch Ophthalmol (Chicago, Ill : 1960) 126(8):1161\u20131163. https:\/\/doi.org\/10.1001\/archophthalmol.2008.1","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"issue":"6","key":"4797_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4103\/ijo.IJO_884_17","volume":"67","author":"P Chandra","year":"2019","unstructured":"Chandra P, Kumawat D, Tewari R, Azimeera S (2019) Post-ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol 67(6):967\u2013969. https:\/\/doi.org\/10.4103\/ijo.IJO_884_17","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"4797_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","volume":"145","author":"G Sahay","year":"2010","unstructured":"Sahay G, Alakhova DY, Kabanov AV (2010) Endocytosis of nanomedicines. Journal of Control Release 145(3):182\u2013195. https:\/\/doi.org\/10.1016\/j.jconrel.2010.01.036","journal-title":"Journal of Control Release"},{"issue":"32","key":"4797_CR15","doi-asserted-by":"publisher","first-page":"E6490","DOI":"10.1073\/pnas.1621240114","volume":"114","author":"SM Sarett","year":"2017","unstructured":"Sarett SM, Werfel TA, Lee L, Jackson MA, Kilchrist KV, Brantley-Sieders D, Duvall CL (2017) Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing. Proc Natl Acad Sci U S A 114(32):E6490\u2013e6497. https:\/\/doi.org\/10.1073\/pnas.1621240114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5076","key":"4797_CR16","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1523409","volume":"257","author":"C Hwang","year":"1992","unstructured":"Hwang C, Sinskey AJ, Lodish HF (1992) Oxidized redox state of glutathione in the endoplasmic reticulum. Science (New York, NY) 257(5076):1496\u20131502","journal-title":"Science (New York, NY)"},{"issue":"9","key":"4797_CR17","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/adhm.201400039","volume":"3","author":"M Wang","year":"2014","unstructured":"Wang M, Alberti K, Varone A, Pouli D, Georgakoudi I, Xu Q (2014) Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles. Adv Healthc Mater 3(9):1398\u20131403. https:\/\/doi.org\/10.1002\/adhm.201400039","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"4797_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1021\/bc200572w","volume":"23","author":"S Sun","year":"2012","unstructured":"Sun S, Wang M, Knupp SA, Soto-Feliciano Y, Hu X, Kaplan DL, Langer R, Anderson DG, Xu Q (2012) Combinatorial library of lipidoids for in vitro DNA delivery. Bioconjug Chem 23(1):135\u2013140. https:\/\/doi.org\/10.1021\/bc200572w","journal-title":"Bioconjug Chem"},{"issue":"1","key":"4797_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10633-009-9181-x","volume":"120","author":"ME Hartnett","year":"2010","unstructured":"Hartnett ME (2010) The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50\/10 OIR model. Doc Ophthalmol Advances in ophthalmology 120(1):25\u201339. https:\/\/doi.org\/10.1007\/s10633-009-9181-x","journal-title":"Doc Ophthalmol"},{"key":"4797_CR20","first-page":"2499","volume":"14","author":"JD Akula","year":"2008","unstructured":"Akula JD, Mocko JA, Benador IY, Hansen RM, Favazza TL, Vyhovsky TC, Fulton AB (2008) The neurovascular relation in oxygen-induced retinopathy. Mol Vis 14:2499\u20132508","journal-title":"Mol Vis"},{"issue":"2","key":"4797_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s1046-2023(02)00023-3","volume":"26","author":"SM Elbashir","year":"2002","unstructured":"Elbashir SM, Harborth J, Weber K, Tuschl T (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods (San Diego, Calif) 26(2):199\u2013213. https:\/\/doi.org\/10.1016\/s1046-2023(02)00023-3","journal-title":"Methods (San Diego, Calif)"},{"issue":"1","key":"4797_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10633-009-9180-y","volume":"120","author":"JM Barnett","year":"2010","unstructured":"Barnett JM, Yanni SE, Penn JS (2010) The development of the rat model of retinopathy of prematurity. Doc Ophthalmol Advances in ophthalmology 120(1):3\u201312. https:\/\/doi.org\/10.1007\/s10633-009-9180-y","journal-title":"Doc Ophthalmol"},{"key":"4797_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-4939-3628-1_22","volume":"1430","author":"MV Gammons","year":"2016","unstructured":"Gammons MV, Bates DO (2016) Models of oxygen induced retinopathy in rodents. Methods Mol Biol (Clifton, NJ) 1430:317\u2013332. https:\/\/doi.org\/10.1007\/978-1-4939-3628-1_22","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"5","key":"4797_CR24","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1167\/iovs.05-1096","volume":"47","author":"E Banin","year":"2006","unstructured":"Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M (2006) T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest Ophthalmol Vis Sci 47(5):2125\u20132134. https:\/\/doi.org\/10.1167\/iovs.05-1096","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4797_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s0002-9440(10)64374-x","volume":"160","author":"D Gebarowska","year":"2002","unstructured":"Gebarowska D, Stitt AW, Gardiner TA, Harriott P, Greer B, Nelson J (2002) Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxia-induced retinal neovascularization. Am J Pathol 160(1):307\u2013313. https:\/\/doi.org\/10.1016\/s0002-9440(10)64374-x","journal-title":"Am J Pathol"},{"issue":"1","key":"4797_CR26","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"4797_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajpath.2011.11.031","volume":"180","author":"H Wang","year":"2012","unstructured":"Wang H, Byfield G, Jiang Y, Smith GW, McCloskey M, Hartnett ME (2012) VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am J Pathol 180(3):1243\u20131253. https:\/\/doi.org\/10.1016\/j.ajpath.2011.11.031","journal-title":"Am J Pathol"},{"issue":"5","key":"4797_CR28","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1542\/peds.2006-1088","volume":"118","author":"MJ Bizzarro","year":"2006","unstructured":"Bizzarro MJ, Hussain N, Jonsson B, Feng R, Ment LR, Gruen JR, Zhang H, Bhandari V (2006) Genetic susceptibility to retinopathy of prematurity. Pediatrics 118(5):1858\u20131863. https:\/\/doi.org\/10.1542\/peds.2006-1088","journal-title":"Pediatrics"},{"issue":"12","key":"4797_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.11622\/smedj.2013246","volume":"54","author":"A Peirovifar","year":"2013","unstructured":"Peirovifar A, Gharehbaghi MM, Gharabaghi PM, Sadeghi K (2013) Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity. Singap Med J 54(12):709\u2013712. https:\/\/doi.org\/10.11622\/smedj.2013246","journal-title":"Singap Med J"},{"issue":"5","key":"4797_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","volume":"63","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF (2018) Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol 63(5):618\u2013637. https:\/\/doi.org\/10.1016\/j.survophthal.2018.04.002","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"4797_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","volume":"114","author":"DS Boyer","year":"2007","unstructured":"Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR (2007) Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114(2):246\u2013252. https:\/\/doi.org\/10.1016\/j.ophtha.2006.10.045","journal-title":"Ophthalmology"},{"issue":"4949 Pt 1","key":"4797_CR32","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL (1990) Direct gene transfer into mouse muscle in vivo. Science (New York, NY) 247(4949 Pt 1):1465\u20131468","journal-title":"Science (New York, NY)"},{"issue":"11","key":"4797_CR33","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1080\/15476286.2017.1341034","volume":"14","author":"X Zhou","year":"2017","unstructured":"Zhou X, Chen X, Wang Y, Feng X, Guang S (2017) A new layer of rRNA regulation by small interference RNAs and the nuclear RNAi pathway. RNA Biol 14(11):1492\u20131498. https:\/\/doi.org\/10.1080\/15476286.2017.1341034","journal-title":"RNA Biol"},{"issue":"6 Suppl","key":"4797_CR34","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1097\/IAE.0b013e3181ad2341","volume":"29","author":"L Singerman","year":"2009","unstructured":"Singerman L (2009) Combination therapy using the small interfering RNA bevasiranib. Retina (Philadelphia, Pa) 29(6 Suppl):S49\u2013S50. https:\/\/doi.org\/10.1097\/IAE.0b013e3181ad2341","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"8","key":"4797_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nbt.3298","volume":"33","author":"A Wittrup","year":"2015","unstructured":"Wittrup A, Ai A, Liu X, Hamar P, Trifonova R, Charisse K, Manoharan M, Kirchhausen T, Lieberman J (2015) Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat Biotechnol 33(8):870\u2013876. https:\/\/doi.org\/10.1038\/nbt.3298","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4797_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1517\/17425247.2016.1134486","volume":"13","author":"Y Jiang","year":"2016","unstructured":"Jiang Y, Huo S, Hardie J, Liang XJ, Rotello VM (2016) Progress and perspective of inorganic nanoparticle-based siRNA delivery systems. Expert Opin Drug Deliv 13(4):547\u2013559. https:\/\/doi.org\/10.1517\/17425247.2016.1134486","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04797-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04797-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T23:53:44Z","timestamp":1625270024000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04797-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4797"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04797-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research involved the use of animals and was performed in accordance with institutional guidelines for the care and use of animals in research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}